Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan for Liver Fibrosis in Chronic Hepatitis C
NCT00930995Phase 2Withdrawn
- Sponsor
- Kaiser Permanente
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of candesartan in hepatitis C (HCV), sponsored by Kaiser Permanente. Status: withdrawn.
02
Drugs
candesartan
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00930995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930995.